BrightSpring Health Services (BTSG) Cash & Equivalents (2023 - 2026)

BrightSpring Health Services' Cash & Equivalents history runs 4 years deep, the most recent figure standing at $888.8 million for Q1 2026.

• Quarterly Cash & Equivalents rose 1598.22% year-over-year to $888.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $888.8 million (up 1598.22% YoY) and the FY2025 annual result came in at $88.4 million, up 44.98% from the prior year.
• Cash & Equivalents was $888.8 million for Q1 2026 at BrightSpring Health Services, up from $88.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $888.8 million in Q1 2026 and bottomed at $13.1 million in Q4 2023.
• A 4-year average of $143.3 million and a median of $59.5 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2025 — Cash & Equivalents fell 9.82% — and 2026, when it surged 1598.22%.
• BrightSpring Health Services' Cash & Equivalents stood at $13.1 million in 2023, then jumped by 366.33% to $61.0 million in 2024, then surged by 44.98% to $88.4 million in 2025, then surged by 905.77% to $888.8 million in 2026.
• Business Quant data shows BTSG's Cash & Equivalents at $888.8 million in Q1 2026, $88.4 million in Q4 2025, and $140.3 million in Q3 2025.